These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 17726608

  • 1. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
    Roggenkämper P.
    Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of carbamazepine combined with botulinum toxin a in the treatment of blepharospasm and hemifacial spasm.
    Li XH, Lin SC, Hu YF, Liu LY, Liu JB, Hong YC.
    Eye Sci; 2012 Dec; 27(4):178-81. PubMed ID: 23225838
    [Abstract] [Full Text] [Related]

  • 3. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
    Sacramento DRC, Lima A, Maia DP, Cunningham M, Maciel RH, Camargos ST, Cardoso F.
    Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
    [No Abstract] [Full Text] [Related]

  • 4. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 5. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA.
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [Abstract] [Full Text] [Related]

  • 6. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP.
    Arq Bras Oftalmol; 2006 Jun; 69(1):23-6. PubMed ID: 16491229
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.
    Jost WH, Kohl A.
    J Neurol; 2001 Apr; 248 Suppl 1():21-4. PubMed ID: 11357234
    [Abstract] [Full Text] [Related]

  • 8. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A.
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [Abstract] [Full Text] [Related]

  • 9. Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm.
    Poonyathalang A, Preechawat P, Jamnansiri U.
    Jpn J Ophthalmol; 2005 Apr; 49(4):327-8. PubMed ID: 16075337
    [No Abstract] [Full Text] [Related]

  • 10. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P, Choolam A, Kulkantrakorn K.
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [Abstract] [Full Text] [Related]

  • 11. Use of botulinum toxin in neuro-ophthalmology.
    O'Day J.
    Curr Opin Ophthalmol; 2001 Dec; 12(6):419-22. PubMed ID: 11734681
    [Abstract] [Full Text] [Related]

  • 12. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F.
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [Abstract] [Full Text] [Related]

  • 13. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
    Winterhoff J, Laskawi R.
    HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
    [Abstract] [Full Text] [Related]

  • 15. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL, Casswell EJ, Salam T, Hersh D, Ortiz-Perez S, Ezra D.
    JAMA Ophthalmol; 2016 Nov 01; 134(11):1247-1252. PubMed ID: 27606483
    [Abstract] [Full Text] [Related]

  • 16. Five-Year Retrospective Review of Cases with Benign Essential Blepharospasm and Hemifacial Spasm Presenting in a Tertiary Eye Care Center in North India.
    Raj A, Arya SK, Deswal J, Bamotra RK.
    Semin Ophthalmol; 2017 Nov 01; 32(3):371-376. PubMed ID: 27078720
    [Abstract] [Full Text] [Related]

  • 17. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR, Erickson JP, Anderson JS, Lee MS.
    Ophthalmic Plast Reconstr Surg; 2008 Nov 01; 24(2):113-6. PubMed ID: 18356715
    [Abstract] [Full Text] [Related]

  • 18. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P, Chaudhary M, Agrawal JP, Shah DN.
    Kathmandu Univ Med J (KUMJ); 2010 Nov 01; 8(31):305-10. PubMed ID: 22610735
    [Abstract] [Full Text] [Related]

  • 19. Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
    Snir M, Weinberger D, Bourla D, Kristal-Shalit O, Dotan G, Axer-Siegel R.
    Am J Ophthalmol; 2003 Jul 01; 136(1):99-105. PubMed ID: 12834676
    [Abstract] [Full Text] [Related]

  • 20. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006 Jul 01; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.